Explore
Porta Sophia

Press Releases

November 14, 2025 | 3rd Party Submission

Syqe Medical Ltd. U.S. Patent Application 19/014,337 | Porta Sophia Files Third Party Submission

Patent application: plant formulations for pulmonary delivery

View Press Release

November 13, 2025 | 3rd Party Submission

Beckley Psytech Limited U.S. Patent Application 19/040,537 | Porta Sophia Files Third Party Submission

Patent application: intranasal 5-MeO-DMT dry powder for treatment of disorders

View Press Release

November 10, 2025 | 3rd Party Submission

Compass Pathfinder LTD U.S. Patent Application 19/236,398 | Porta Sophia Files Third Party Submission

Patent application: a crystalline polymorph of psilocybin hydrate

View Press Release

November 7, 2025 | 3rd Party Submission

UNIVERSITÄTSSPITAL BASEL U.S. Patent Application 19/020,135 | Porta Sophia Files Third Party Submission

Patent application: LSD for the treatment of Generalized Anxiety Disorder

View Press Release

October 31, 2025 | 3rd Party Submission

RESET PHARMACEUTICALS, INC U.S. Patent Application 18/865,125 | Porta Sophia Files Third Party Submission

Patent application: IV psilocybin/psilocin for treatment of mood & substance disorders

View Press Release

October 29, 2025 | 3rd Party Submission

GH Research Ireland Ltd U.S. Patent Application 18/679,917 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT compositions for treating mental disorders

View Press Release

September 12, 2025 | 3rd Party Submission

PAX LABS, INC U.S. Patent Application 18/910,751 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT vape compositions for treatment of psychological disorders

View Press Release

September 9, 2025 | 3rd Party Submission

Belnap Pharmaceuticals, LLC U.S. Patent Application 18/833,862 | Porta Sophia Files Third Party Submission

Patent application: oxytocin and psychedelics for treating mood, anxiety, pain, and eating disorders

View Press Release

August 18, 2025 | 3rd Party Submission

Journey Colab Corp. U.S. Patent Application 18/720,892 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for the treatment of Substance Use Disorders

View Press Release
Learn about the status and impact of Porta Sophia's third party submissions and observations.

View Our Summary Chart